TP53 mutation has been identified in approximately half of all cancers, and analysis of the MSK MetTropism database on the cBioPortal website shows that the mutation frequencies vary according to the type of cancer (Figure 1) (14, 15). This evidence concerns the gene TP53 and cancer.